Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Change in Acquisitions & Divestments (2020 - 2021)

Design Therapeutics' Change in Acquisitions & Divestments history spans 2 years, with the latest figure at $200000.0 for Q4 2021.

  • For Q4 2021, Change in Acquisitions & Divestments fell 90.06% year-over-year to $200000.0; the TTM value through Dec 2021 reached $34.2 million, changed N/A, while the annual FY2025 figure was $314.9 million, 14.72% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2021 was $200000.0 at Design Therapeutics, down from $245000.0 in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $28.2 million in Q1 2021 and bottomed at $200000.0 in Q4 2021.